|
|
|
|
|
|
|
|
|
Exhibit 99.4
|
PFIZER INC |
||||||||||||
|
SEGMENT/PRODUCT REVENUES |
||||||||||||
|
FOURTH QUARTER 1999 |
||||||||||||
|
(millions of dollars) |
||||||||||||
|
***********QUARTER-TO-DATE************ |
||||||||||||
|
WORLDWIDE |
U.S. |
INTERNATIONAL |
||||||||||
|
1999 |
1998 |
% |
1999 |
1998 |
% |
1999 |
1998 |
% |
||||
|
TOTAL REVENUES |
7,534 |
6,551 |
15 |
4,581 |
3,791 |
21 |
2,953 |
2,760 |
7 |
|||
|
PHARMACEUTICALS |
6,113 |
5,221 |
17 |
3,896 |
3,175 |
23 |
2,217 |
2,046 |
8 |
|||
|
TOTAL HUMAN PHARMACEUTICALS |
5,598 |
4,744 |
18 |
3,649 |
2,978 |
23 |
1,949 |
1,766 |
10 |
|||
|
- CARDIOVASCULAR DISEASES |
2,485 |
1,963 |
27 |
1,483 |
1,154 |
29 |
1,002 |
809 |
24 |
|||
|
LIPITOR |
1,134 |
719 |
58 |
809 |
521 |
55 |
325 |
198 |
64 |
|||
|
NORVASC |
807 |
710 |
14 |
364 |
317 |
15 |
443 |
393 |
13 |
|||
|
CARDURA |
213 |
183 |
16 |
92 |
81 |
13 |
121 |
102 |
18 |
|||
|
ACCUPRIL/ACCURETIC |
136 |
116 |
17 |
74 |
58 |
29 |
62 |
58 |
6 |
|||
|
PROCARDIA XL |
138 |
169 |
(18) |
138 |
169 |
(18) |
0 |
0 |
--- |
|||
|
- INFECTIOUS DISEASES |
1,032 |
1,019 |
1 |
672 |
617 |
9 |
360 |
402 |
(10) |
|||
|
ZITHROMAX |
449 |
372 |
21 |
377 |
298 |
27 |
72 |
74 |
(3) |
|||
|
DIFLUCAN |
276 |
245 |
13 |
134 |
116 |
16 |
142 |
129 |
10 |
|||
|
VIRACEPT |
123 |
158 |
(22) |
123 |
111 |
11 |
0 |
47 |
(100) |
|||
|
TROVAN |
(5) |
55 |
--- |
(3) |
50 |
--- |
(2) |
5 |
--- |
|||
|
- CENTRAL NERVOUS SYSTEM |
898 |
764 |
18 |
718 |
605 |
19 |
180 |
159 |
13 |
|||
|
ZOLOFT |
507 |
481 |
6 |
405 |
379 |
7 |
102 |
102 |
1 |
|||
|
NEURONTIN |
294 |
164 |
79 |
259 |
143 |
80 |
35 |
21 |
68 |
|||
|
ARICEPT* |
28 |
21 |
31 |
0 |
0 |
--- |
28 |
21 |
31 |
|||
|
- DIABETES |
211 |
273 |
(23) |
202 |
263 |
(23) |
9 |
10 |
(7) |
|||
|
GLUCOTROL XL |
67 |
58 |
16 |
63 |
55 |
14 |
4 |
3 |
57 |
|||
|
REZULIN |
135 |
203 |
(33) |
135 |
202 |
(33) |
0 |
1 |
(41) |
|||
|
- ALLERGY |
134 |
108 |
24 |
134 |
107 |
25 |
0 |
1 |
(50) |
|||
|
ZYRTEC |
133 |
107 |
24 |
133 |
106 |
25 |
0 |
1 |
(50) |
|||
|
- VIAGRA |
277 |
233 |
19 |
161 |
128 |
25 |
116 |
105 |
11 |
|||
|
- ALLIANCE REVENUE (Aricept |
214 |
28 |
652 |
197 |
28 |
599 |
17 |
0 |
M+ |
|||
|
- CAPSUGEL |
101 |
95 |
6 |
43 |
41 |
7 |
58 |
54 |
6 |
|||
|
- ANIMAL HEALTH |
414 |
382 |
9 |
204 |
156 |
31 |
210 |
226 |
(7) |
|||
|
CONSUMER PRODUCTS |
1,421 |
1,330 |
7 |
685 |
616 |
11 |
736 |
714 |
3 |
|||
|
- CONSUMER HEALTH CARE |
642 |
588 |
9 |
399 |
353 |
13 |
243 |
235 |
3 |
|||
|
- CONFECTIONERY PRODUCTS |
527 |
504 |
4 |
203 |
191 |
6 |
324 |
313 |
3 |
|||
|
- SHAVING PRODUCTS |
201 |
189 |
6 |
62 |
53 |
17 |
139 |
136 |
2 |
|||
|
- TETRA |
51 |
49 |
4 |
21 |
19 |
7 |
30 |
30 |
1 |
|||
* - Represents direct sales under license agreement with Eisai Co., Ltd.
M+ - Change greater than one thousand percent.
Restated to reflect the merger with Warner-Lambert Company in June 2000, which was accounted for as a pooling of interests.
Certain amounts and percentages may reflect rounding adjustments.
Certain prior year data have been reclassified to conform to the current year presentation.
|
|